RSV Vaccine Now Funded for Eligible Older Adults from 15 May 2026 From 15 May…
Free RSV Vaccine to Be Available for Older Australians from 15 May
Older Australians will soon be able to access a free respiratory syncytial virus (RSV) vaccine through the National Immunisation Program (NIP).
From 15 May 2026, the RSV vaccine Arexvy® will be funded for:
- Adults aged 75 years and over
- Aboriginal and Torres Strait Islander people aged 60 years and over
RSV is a common respiratory virus that can lead to serious illness, hospitalisation, and complications in older adults. The vaccine is designed to help reduce the risk of severe RSV disease.
Eligible people will be able to receive the vaccine through participating GPs, pharmacies, immunisation clinics, Aboriginal health services, and community health providers.
Current guidance recommends a single dose of RSV vaccine for eligible older adults. Protection is expected to last for at least two years, and no booster dose is currently recommended.
The RSV vaccine can also be administered at the same visit as other vaccines, including influenza, COVID-19, pneumococcal, and shingles vaccines.
Without NIP funding, the vaccine would typically cost around $300.
Contact us at Doctors on Nicholson to find out if you are eligible
Book Appointment